CPIX

CUMBERLAND PHARMACEUTICALS INC repurchases.

BuybackStocks tracks every share-repurchase filing CUMBERLAND PHARMACEUTICALS INC (CPIX) submits to SEC EDGAR. Current board authorization stands at $5M. Below: 1 editorial summary of recent filings, plus quarterly execution detail from SEC XBRL data.

Authorization$5M
Filings tracked1

Recent repurchase filings

Every Form 8-K authorization, 10-Q issuer-purchase table, and 10-K disclosure for CUMBERLAND PHARMACEUTICALS INC, sourced from SEC EDGAR and editorialized by BuybackStocks.

8-K · 2026-07-13 New authorization

CUMBERLAND PHARMACEUTICALS INC — $5M

View the full editorial summary with source quote, key facts, and what-this-means analysis.

Related

See the wider context for this program: the Top 20 repurchases of 2026, the highest repurchase yield small-caps ranking, the Q3 2026 small-cap filings report, our glossary, or the live SEC filings feed.